Skip to content

Evidence Hub

Publication
Feb 14, 2023

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Importance Understanding the effect of serum antibodies to severe acute respiratory ...
Start Reading
Publication
Feb 14, 2023

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study

Background Chronic kidney disease (CKD), one of the most common complications of type 2 ...
Start Reading
Publication
Feb 14, 2023

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US

Objectives There is lack of clarity regarding the role of angiotensin receptor blockers ...
Start Reading
Publication
Feb 14, 2023

Learning from the past to advance tomorrow's real world evidence: what demonstration projects have to teach us.

Regulators, health technology assessment (HTA) agencies, and payers are actively ...
Start Reading
Publication
Feb 14, 2023

A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022

Background There is a dearth of drug utilization studies for coronavirus disease 2019 ...
Start Reading
Publication
Feb 14, 2023

Healthcare Resource Utilization and Baseline Characteristics of Patients With Generalized Pustular Psoriasis: Real-World Results From a Large US Database of Multiple Commercial Medical Insurers

Background: Generalized pustular psoriasis (GPP) is a rare, severe neutrophilic skin ...
Start Reading
Publication
Feb 14, 2023

Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis

Background Few studies have evaluated the clinical burden of concomitant joint disease in ...
Start Reading
Publication
Feb 14, 2023

Clinical characteristics and healthcare resource utilization in patients with generalized pustular psoriasis: real-world evidence from a large claims-based dataset

Background: Generalized pustular psoriasis (GPP) is a rare, severe neutrophilic skin ...
Start Reading
Publication
Feb 14, 2023

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

INTRODUCTION The emergence of three lethal coronaviruses in <20 years and the urgency ...
Start Reading
Publication
Feb 14, 2023

First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

Introduction Inhaled corticosteroids (ICS) are often prescribed inappropriately alongside ...
Start Reading
Publication
Feb 14, 2023

Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate

Background: New hereditary angioedema (HAE) treatments have become available in recent ...
Start Reading
Publication
Feb 14, 2023

Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.

Background: Regulators are evaluating the use of noninterventional real-world evidence ...
Start Reading
Publication
Feb 14, 2023

iGlarLixi vs. premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: SoliComplex real-world study

Aim To compare outcomes in adults with type 2 diabetes (T2D) suboptimally controlled with ...
Start Reading
Publication
Feb 14, 2023

Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims

Introduction The aim of this work is to evaluate baricitinib safety with respect to ...
Start Reading
Publication
Feb 14, 2023

Effects of expanding the look‐back period to all available data in the assessment of covariates

Background A fixed baseline period has been a common covariate assessment approach in ...
Start Reading
Publication
Feb 14, 2023

Transferability of real-world data across borders for regulatory and health technology assessment decision-making

Recently, there has been increased consideration of real-world data (RWD) and real-world ...
Start Reading
Publication
Feb 14, 2023

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Background: Many studies reporting coronavirus disease 2019 (COVID-19) complications have ...
Start Reading
Publication
Feb 14, 2023

Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database

Objective To examine the screening rates for kidney damage and function among patients ...
Start Reading
Publication
Feb 14, 2023

SURF: A Screening tool (for manufacturers) to evaluate whether Using real-world data to support an effectiveness claim in an FDA application has Regulatory Feasibility

Based on recent guidance and publicly available approvals, the US Food and Drug ...
Start Reading
Publication
Feb 14, 2023

The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework

To complement real-world evidence (RWE) guidelines, the 2019 Structured Preapproval and ...
Start Reading
Publication
Feb 14, 2023

Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States

Background Idiopathic hypersomnia is a debilitating sleep disorder; however, little is ...
Start Reading
Publication
Feb 14, 2023

[RCT-D] Non-randomized healthcare database studies and their agreement with 32 emulated randomized controlled trials

Importance Nonrandomized studies using insurance claims databases can be analyzed to ...
Start Reading
Publication
Feb 14, 2023

The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation (CARE) Initiative: Oncology

Legislative and technological advancements over the past decade have given rise to the ...
Start Reading
Publication
Feb 14, 2023

Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study

Background: Nonadherence to systemic treatments for psoriasis leads to treatment failure ...
Start Reading